NanoSphere Health Sciences Inc.
NSHS
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 700.00 | 700.00 | 1.90K | 2.50K | 4.10K |
| Total Receivables | 16.10K | 16.10K | 15.00K | 13.70K | 13.40K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 16.80K | 16.80K | 16.80K | 16.20K | 17.50K |
|
|
|||||
| Total Current Assets | 16.80K | 16.80K | 16.80K | 16.20K | 17.50K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 16.80K | 16.80K | 16.80K | 16.20K | 17.50K |
|
|
|||||
| Total Accounts Payable | 736.80K | 736.80K | 605.50K | 691.40K | 606.00K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 76.50K | 76.50K | 63.40K | 48.60K | 48.40K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 609.80K | 609.80K | 699.00K | 648.40K | 745.50K |
| Total Other Current Liabilities | 609.80K | 609.80K | 699.00K | 648.40K | 745.50K |
| Total Current Liabilities | 1.42M | 1.42M | 1.37M | 1.39M | 1.40M |
|
|
|||||
| Total Current Liabilities | 1.42M | 1.42M | 1.37M | 1.39M | 1.40M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 76.50K | 76.50K | 63.40K | 48.60K | 48.40K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.42M | 1.42M | 1.37M | 1.39M | 1.40M |
|
|
|||||
| Common Stock & APIC | 18.76M | 18.76M | 18.76M | 18.76M | 18.76M |
| Retained Earnings | -21.46M | -21.46M | -21.37M | -21.41M | -21.39M |
| Treasury Stock & Other | 1.29M | 1.29M | 1.25M | 1.27M | 1.25M |
| Total Common Equity | -1.41M | -1.41M | -1.35M | -1.37M | -1.38M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.41M | -1.41M | -1.35M | -1.37M | -1.38M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.41M | -1.41M | -1.35M | -1.37M | -1.38M |
|
|
|||||